Myriad Genetics derivative lawsuit settled; court approves $950k fee award, dismisses claims with prejudice

MYRIAD GENETICS INC

Court approves global settlement of shareholder derivative litigation; no admission of liability.
Company pays $950,000 in attorneys' fees and expenses; adopts corporate governance reforms.
Consolidated Delaware derivative actions and federal derivative action dismissed with prejudice.
Settlement relates to complaints alleging fiduciary duty breaches by former and current directors/officers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.